Extension of Expiration Date for PAR-18-174 "Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)"

Notice Number: NOT-AG-18-002

Key Dates
Release Date: February 01, 2018

Related Announcements
PAR-18-174

Issued by
National Institute on Aging (NIA)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-18-174 "Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)" will be extended by one receipt cycle. Therefore, Part I, Key Dates, Expiration Date has been modified as follows:

Current Language
Expiration Date: May 8, 2018

Revised Language
Expiration Date: September 8, 2018

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lorenzo M. Refolo, Ph.D.
National Institute on Aging (NIA)
Telephone:301-594-7576
Email: refolol@nih.gov